The FDA has made public dozens of warning letters sent to drug companies accused of misleading or deceptive advertising.  The disclosures come after the agency said Sept. 9 it would be sending thousands of warning letters and 100 cease-and-desist letters to drug companies over deceptive advertising. 

A day later, President Donald Trump signed an executive order directing HHS and the FDA to require drug companies to include full safety warnings in advertisements. The warning letters outline alleged violations and can lead to regulatory action if companies choose to not comply.  The post FDA warns drugmakers over advertising practices appeared first on Becker's Hospital Review | Healthcare News & Analysis.

See Full Page